Cargando…
Unilateral Pleural Effusion after Third Dose of BNT162b2 mRNA Vaccination: Case Report
Vaccination remains the best strategy against coronavirus disease 2019 (COVID-19) in terms of prevention. The efficacy and safety of COVID-19 vaccines is supported by well-designed clinical trials that recruited many participants. It is well-known that vaccination is associated with local side effec...
Autores principales: | Athanasiou, Nikolaos K., Antonoglou, Archontoula, Ioannou, Marios, Jahaj, Edison, Katsaounou, Paraskevi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054106/ https://www.ncbi.nlm.nih.gov/pubmed/36983574 http://dx.doi.org/10.3390/jpm13030391 |
Ejemplares similares
-
Persistent Endothelial Lung Damage and Impaired Diffusion Capacity in Long COVID
por: Asimakos, Andreas T., et al.
Publicado: (2023) -
BNT162B2 MRNA BOOSTER VACCINE-RELATED PERICARDITIS: A CASE COMPLICATED BY PERICARDIAL AND PLEURAL EFFUSIONS
por: WHITE, ANESHA, et al.
Publicado: (2022) -
Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
por: Patalon, Tal, et al.
Publicado: (2022) -
Unilateral pleural effusion with capillary haemangioma
por: Kadota, Nozomi, et al.
Publicado: (2020) -
Myopericarditis with hemorrhagic pericardial effusion following BNT162b2 mRNA COVID-19 vaccine()
por: Generette, Gabriela S., et al.
Publicado: (2022)